Peptide APIs: Market Size & Forecast 2026

The global peptide API market reached approximately USD 5.0 billion in 2025, anchored by GLP-1 receptor agonist demand that has fundamentally re-rated the manufacturing capacity landscape. Solid-phase peptide synthesis (SPPS) remains the dominant production chemistry, with amino acid feedstock representing 50-70% of COGS. A handful of specialist CDMOs control the majority of commercial-scale capacity; lead times for complex GLP-1 APIs stretch to 12-18 months, giving suppliers structural leverage over buyers in the near term. Regulatory frameworks from FDA, EMA, and ICH Q7 set the compliance baseline, while the EMA's finalized guideline on impurities in long peptides (effective June 2024, with a 0.1% reporting threshold) adds specificity to quality expectations. > Synthesised from secondary and publicly verifiable sources via Claight Category Watch:

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.